14^th International Conference on Cancer Stem Cell & Oncology Research October 30-31, 2023 Rome, Italy

Dr. Mariana Argenziano is a Research Associate faculty at the University of Florida’s Heart Institute and Morsani College of Medicine. She has received a PhD from the University of San Martin (Buenos Aires, Argentina) in 2014 and trained as a postdoctoral researcher at the Universities of Illinois and Pennsylvania.

Cardiovascular regenerative medicine Development of organoids models for cardiac disease Effect of air pollution on cardiovascular disease

Dr. Ebrahim Mostafavi is currently at Stanford Cardiovascular Institute, School of Medicine. His research interests revolve around the use of cardiac iPS cells to design and develop in vitro models for cardiovascular disease modeling and drug screening. Dr. Mostafavi received his PhD in Chemical Engineering (with a focus on Biomedical Engineering, Biomaterials, Tissue Engineering and Regenerative Medicine) from Northeastern University, Boston, MA. During his doctoral training, he received several prestigious awards. Dr. Mostafavi serves as an Associate Editor-in-Chief for the International Journal of Nanomedicine (IF= 5.115, 5-year IF= 5.166, Q1 Bioengineering). He also serves as a verified peer-reviewed (50+ documents) for over 18 different high-impact journals from prestigious publishers such as Nature, Elsevier, Springer Nature, Wiley, Taylor & Francis, Dove Press, PLOS, IOPscience, etc. His scholarly work consists of > 40 publications with an H-index of 17 (i10-index= 22) on Google Scholar Profile. He also contributed to 7 book chapters and was selected as the editor of a few books, including “Advances in Cardiovascular Biomaterials” and "Emerging Nanomaterials to Combat Antimicrobial Resistance.

Dr. Ebrahim Mostafavi research interests revolve around the use of cardiac iPS cells to design and develop in vitro models for cardiovascular disease modeling and drug screening

Marek Malecki MD PhD is President of Phoenix Biomolecular Engineering Foundation, Chief Executive Officer of the Center for Molecular Medicine, and Visiting Professor at the University of Wisconsin. He earned MD degree at the Medical Academy, Poznan followed by Residency/Fellowship in Molecular Medicine in Rigshospitalet, Copenhagen. He earned PhD at the National Academy of Sciences, Warsaw followed by the postdoctoral fellowships in molecular biology at the Austrian Academy of Sciences, Karolinska Institutet, Stockholm, Salzburg and Vienna, ETH, Zurich, Utrecht University Medical School, Utrecht, Cancer Center, Vienna, Cancer Center, Amsterdam, Biozentrum, Basel. Dr Malecki developed a novel technology to identify and isolate single living pluripotent stem cells followed by their clonal expansion and molecular profiling including sequencing their proteomes, transcriptomes, and genomes. This technology serves also for reprogramming the stem cells for their use as the vectors in gene therapy of cancer. The technology, protected by the US and WIPO, is currently streamlined to clinical trials. He is the first author on the peer-reviewed articles. He is often an invited speaker and courses’ faculty at the international professional conferences. Dr Malecki is Editor in Chief of the Journal of Genetic Syndromes and Gene Therapy and Member of the Editorial Boards for many high-impact professional journals. He is the member of the American Medical Association, American Association of Human Genetics, American Antibody Society, Southern California Biotechnology Council, and Rho Chi Honor Society for Excellence in Teaching and as the Faculty Role Model.

cancers of ovaries, cancers of testes, cancer stem cells (CSC), circulating tumor cells (CTCs), genetic disorders, iatrogenic genetic mutations, gene therapy, targeted gene delivery, fertility sparing therapy, biobanking, in vitro fertilization.

Alex F. Chen is Director of VA Vascular Surgery Research, and an Associate Professor, Department of Surgery, University of Pittsburgh School of Medicine. He has received a MD from Hunan Medical University in 1985 and a PhD in Pharmacology from Southern Illinois University in 1995. He is serving as an editorial board member of several reputed journals.

Vascular and endothelial cell biology Endothelial progenitor cells Redox regulation of endothelial function in diabetes and hypertension.

Min Du is Professor and Endowed (Funded) Chair, Department of Animal Sciences, Washington State University, Pullman, WA. and Leader of Development Biology Group, Department of Animal Science, Associate Professor in Muscle Biology, Associate Professor of Biomedical Program, Associate Professor of Molecular and Cellular Life Sciences, University of Wyoming. He has received a PhD in Muscle Biology from Iowa State University, Ames, IA in, 1998-2001. He has completed his M.S. in Muscle Biology in China Agricultural University, Beijing, China (1993). He has obtained his B.S. in Food Engineering in Zhejiang Agricultural University, Hangzhou, China (1990). He received Early Career Achievement Award, form American Society of Animal Science. He is serving as an associate editor for Journal of Animal Science, reviewer for more than 20 journals and several federal funding agencies. He has published more than 100 peer-reviewed papers in muscle biology.

Skeletal muscle development Mesenchymal stem cell differentiation Myogenesis Adipogenesis Fibrogenesis Cell signaling and gene expression Epigenetic modifications.

Fazlul H. Sarkar, Ph.D. is a Professor at Karmanos Cancer Center, Wayne State University with a track-record of cancer research for over 32 years. He received his Ph.D. degree in biochemistry and completed his post-doctoral training in molecular biology at Memorial Sloan Kettering Cancer Center in New York. His work has led to the discovery of the role of chemopreventive agents in sensitization of cancer cells (reversal of drug-resistance) to conventional therapeutics (chemo-radio-therapy). He has published over 400 original scientific articles in peer-reviewed journals, review articles and book chapters. He is currently a Senior Editor of the journal: Molecular Cancer Therapeutics and member of the editorial board of many scientific journals.

His research is focused on understanding the role of a master transcription factor, NF-B, and further directed toward elucidating the molecular mechanisms of action of natural agents and synthetic small molecules for cancer prevention and therapy.

1991 Master degree in Neurology and Neurosurgery from McGill University, Montreal,Quebec, Canada. Work performed at the Montreal Neurological Institute.Thesis on epileptogenesis and the role of eicosanoids in long-term potentiation.1987 Bachelor degree in Honors Neurophysiology from McGill University, Montreal, Quebec, Canada. Program limited to 6 students.

Neurology and Neurophysiology.

He received his Ph.D from University of Leeds. His Research focuses on Regenerative Medicine,Tissue Engineering Biomaterials, Stem Cell Technology, Metabolic Bone Disease, Musculoskeletal Injuries, Soft tissue and Ligament regeneration, Bone regeneration, Molecular Biology, Cell Culture, Cell Biology, Stem Cells, Life Sciences

Strategies for effective isolation of Stem cells to achieve off-the shelf painless and hazard-free regenerative medicine products, Stem cell musculoskeletal therapy and Bone tissue engineering using natural scaffolds, Stem cells to treat cardiac and neuroral disorders (such as Heart infraction, Parkinson’s disease and Multiple sclerosis)

Medical doctor and Scientist. I am specialized in cell engineering and the development of cell production process for cell therapy. I worked also on impact of malignant myeloma on mesenchymal stem cells. I have a very good experience in the management of project development in cell therapy. I am a specialist in adult stem cells (hematopoietic stem cells and mesenchymal stromal cells from bone marrow and adipose tissue). I have built a production process of adipose-tissue derived stromal/stem cells that is used in clinical trials. Finally I was in charge of programs of production of induced-pluripotent stem cells (iPS) and their differentiation into cardiovascular progenitors in my last position.

Cell engineering, cell culture, flow cytometry, laboratory management, stem cells, adipose-derived stromal/stem cells, mesenchymal stem cells

My current position is as an Assistant Professor of Laboratory Hematology and Transfusion Medicine in Technological Institute Education (T.E.I.) of Athens, Faculty of Health and Caring Professors, Department of Medical Laboratories. My research interests are the red blood cell storage lesion, the erythrocyte aging and red blood cell programmed cell death, eryptosis in vivo, ex vivo and in vitro. I am skilled on flow cytometer, SDS-PAGE, western blood, Eliza and many others techniques. I study the red blood cell apoptosis, aging and clearance using monoclonal antibodies and annexin V. Also, by flow cytometry I am able to detect microparticles and I can characterise these. My new research interest is the red cell microparticles in health and many diseases.

My new research interest is the red cell microparticles in health and many diseases.